GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Paradigm Biopharmaceuticals PAR.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Paradigm Biopharmaceuticals

Our reporting

We have not reported on Paradigm Biopharmaceuticals yet.

Next results

24 Feb 2027

Due on 24 Feb 2027.

Past results

Reported against what analysts expected

27 Aug 202626 Feb 202629 Aug 202528 Apr 202527 Feb 202527 Feb 2024
Earnings per share-0.10-0.06-0.03-0.02-0.02-0.16
RevenueA$55,000A$25,150A$35,420A$16,700A$16.7mA$1.3m
ForecastA$55,000A$25,150A$37,051A$35,420—A$18.4m

Key events

  1. 19 Aug 2015Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.